MedPath

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

Registration Number
NCT02489968
Lead Sponsor
Boehringer Ingelheim
Brief Summary

Two independent study parts (i.e. Part A and Part B) are included in this trial. Part A will evaluate empagliflozin 10 mg + linagliptin and Part B will evaluate empagliflozin 25 mg + linagliptin. All analyses will be carried out separately for these study parts. The objective of Part A is to investigate the efficacy, safety and tolerability of the fixed dose combination (FDC) of empagliflozin 10 mg / linagliptin 5 mg compared with empagliflozin 10 mg plus FDC matching placebo administered orally once daily for 24 weeks in Japanese patients with T2DM (Type 2 Diabetes Mellitus) who have insufficient glycaemic control after 16 weeks of treatment with empagliflozin 10 mg alone once daily. The study is designed to show superiority of the FDC of empagliflozin 10 mg / linagliptin 5 mg over empagliflozin 10 mg plus FDC matching placebo after 24 weeks of treatment. The objective of Part B is to investigate the efficacy, safety and tolerability of the FDC of empagliflozin 25 mg / linagliptin 5 mg compared with empagliflozin 25 mg plus FDC matching placebo administered orally once daily for 24 weeks in Japanese patients with T2DM who have insufficient glycaemic control after 16 weeks of treatment with empagliflozin 25 mg alone once daily. The study is designed to show superiority of the FDC of empagliflozin 25 mg / linagliptin 5 mg over empagliflozin 25 mg plus FDC matching placebo after 24 weeks of treatment. The 24 week treatment period will be followed by a 28 week extension treatment period to evaluate further efficacy and safety up to 52 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
880
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
empagliflozin 10 mg + linagliptin 5 mgempagliflozin 10 mg + linagliptin 5 mgpatient to receive a tablet containing low dose empagliflozin and linagliptin once daily
empagliflozin 25 mg + linagliptin 5 mgempagliflozin 25 mg + linagliptin 5 mgpatient to receive a tablet containing high dose empagliflozin and linagliptin once daily
empagliflozin 10 mgempagliflozin 10 mgpatient to receive a tablet containing low dose empagliflozin once daily
empagliflozin 25 mgempagliflozin 25 mgpatients to receive a tablet containing high dose empagliflozin once daily
empagliflozin 10 mgPlacebopatient to receive a tablet containing low dose empagliflozin once daily
empagliflozin 25 mgPlacebopatients to receive a tablet containing high dose empagliflozin once daily
Primary Outcome Measures
NameTimeMethod
Change in Glycated Haemoglobin A1c (HbA1c) (%) From Baseline After 24 Weeks of TreatmentBaseline and 24 week

Change from baseline in HbA1c (%) after 24 weeks of treatment with double-blind trial medication. Change was calculated as: HbA1c value at 24-week - HbA1c value at baseline, for each patient. Baseline was defined as the last observation before the first intake of double-blind randomised trial medication. Statistical analysis presented is based on a restricted maximum likelihood (REML)-based mixed model repeated measures (MMRM) approach. Full Analysis Set (Observed Cases) \[FAS (OC)\]: This analysis set consisted of all patients who were randomised and treated with at least 1 dose of trial drug during the double-blind part of the trial and who had a baseline HbA1c assessment and at least 1 on-treatment HbA1c assessment during the 24-week double-blind part of the trial. Observed cases analysis included only the available data that were observed while patients were on treatment, i.e., excluding the missing data.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (83)

Ebetsu Internal Medicine Clinic

🇯🇵

Hokkaido, Ebetsu, Japan

Iida Medical Clinic

🇯🇵

Hokkaido, Hakodate, Japan

Morinagaueno clinic, Kumamoto, Digestive Tract I.M.

🇯🇵

Kumamoto, Kumamoto, Japan

AGE Makita Medical Clinic

🇯🇵

Tokyo, Chuo-ku, Japan

Kanda Clinic, Tokyo, I.M.

🇯🇵

Tokyo, Japan

Shin Yukuhashi Hospital

🇯🇵

Fukuoka, Yukuhashi, Japan

Odayaka Life Naika Clinic, Saitama, I.M.

🇯🇵

Saitama, Koshigaya, Japan

Hamamatsu Rosai Hospital

🇯🇵

Shizuoka, Hamamatsu, Japan

Nihonbashi Sakura Clinic

🇯🇵

Tokyo, Chuo-ku, Japan

Fukuwa Clinic

🇯🇵

Tokyo, Chuo-ku, Japan

Kikuchi Naika Clinic, Gunma, I.M.

🇯🇵

Gunma, Maebashi, Japan

Manda Memorial Hospital

🇯🇵

Hokkaido, Sapporo, Japan

Japan Community Health Care Organization Hokkaido Hospital

🇯🇵

Hokkaido, Sapporo, Japan

Kumamoto University Hospital

🇯🇵

Kumamoto, Kumamoto, Japan

Clinic Sugiyama, Yamagata, I.M.

🇯🇵

Yamagata, Yamagata, Japan

Tokai Memorial Hospital

🇯🇵

Aichi, Kasugai, Japan

Japan Organization of Occupational Health and Safety Chubu Rosai Hospital

🇯🇵

Aichi, Nagoya, Japan

Kunisaki Makoto Clinic, Fukuoka, I.M./CV Med.

🇯🇵

Fukuoka, Fukuoka, Japan

Fukuoka Shin Mizumaki Hospital

🇯🇵

Fukuoka, Onga, Japan

Hashimoto I.M., Gifu, I.M.

🇯🇵

Gifu, Gifu, Japan

Hasegawa Internal Medicine Clinic

🇯🇵

Hokkaido, Chitose, Japan

Honda Hidehiko Clinic

🇯🇵

Tokyo, Ota-ku, Japan

Murakami Memorial Hp., Ehime, I.M.

🇯🇵

Ehime, Saijo, Japan

Hakodate Koseiin Hakodate Central General Hospital

🇯🇵

Hokkaido, Hakodate, Japan

Uehara Clinic

🇯🇵

Hokkaido, Sapporo, Japan

Namegata District General Hospital

🇯🇵

Ibaraki, Namegata, Japan

Oikawa Clinic

🇯🇵

Iwate, Morioka, Japan

Hirano Medical Clinic

🇯🇵

Iwate, Morioka, Japan

Tokuyama Clinic

🇯🇵

Chiba, Chiba, Japan

Tanaka Int. Clinic, Ehime, DIA Med.,CV Med.

🇯🇵

Ehime, Niihama, Japan

Kurihara Clinic

🇯🇵

Hokkaido, Sapporo, Japan

Sapporo Diabetes, Thyroid Clinic

🇯🇵

Hokkaido, Sapporo, Japan

Hokuriku Hp., Ishikawa, I.M.

🇯🇵

Ishikawa, Kanazawa, Japan

Ashiya Municipal Hospital

🇯🇵

Hyogo, Ashiya, Japan

Itabashi DIA Med. and DERM Clinic, Ibaraki, I.M.

🇯🇵

Ibaraki, Koga, Japan

Takai Naika Clinic

🇯🇵

Kanagawa, Kamakura, Japan

Nagatsuta Family Clinic, Kanagawa, I.M.

🇯🇵

Kanagawa, Yokohama, Japan

Jinnouchi Clinic Diabetes Care Center

🇯🇵

Kumamoto, Kumamoto, Japan

Iwamoto Clinic, Kagawa, DIAB I.M.

🇯🇵

Kagawa, Zentsuji, Japan

Tenpozan Clinic of I.M., Kagoshima, I.M.

🇯🇵

Kagoshima, Kagoshima, Japan

Hayashi DIA Clinic, Kanagawa, DIA Tract Med.·I.M.

🇯🇵

Kanagawa, Chigasaki, Japan

Motomachi Takatsuka Naika Clinic, Kanagawa, I.M.

🇯🇵

Kanagawa, Yokohama, Japan

Kajiyama Clinic, Kyoto, I.M.

🇯🇵

Kyoto, Kyoto, Japan

Matsumoto Nakagawa Hospital

🇯🇵

Nagano, Matsumoto, Japan

Saiseikai Niigata Daini Hp., Niigata, METAB ENDO

🇯🇵

Niigata, Niigata, Japan

Tsuyama Chuo Hospital

🇯🇵

Okayama, Tsuyama, Japan

Yokohama Minoru Clinic

🇯🇵

Kanagawa, Yokohama, Japan

Ota DIA I.M. Clinic, Nagano, I.M.

🇯🇵

Nagano, Nagano, Japan

Nanko Clinic, Osaka, I.M.

🇯🇵

Osaka, Osaka, Japan

Yaesu Clinic, Okinawa, I.M.

🇯🇵

Okinawa, Naha, Japan

Tanaka Clinic, Okinawa, I.M.

🇯🇵

Okinawa, Tomigusuku, Japan

Umeda Oak Clinic, Osaka, I.M.

🇯🇵

Osaka, Osaka, Japan

Ikeoka Clinic, Osaka, I.M.

🇯🇵

Osaka, Osaka, Japan

Shiraiwa Medical Clinic, Osaka, I.M.

🇯🇵

Osaka, Japan

Medical corporation Chisei-kai Watanabe clinic

🇯🇵

Saitama, Okegawa, Japan

Kinugawa CARDIOL Clinic, Osaka, I.M.

🇯🇵

Osaka, Osaka, Japan

OCROM Clinic

🇯🇵

Osaka, Suita, Japan

AMC Nishi-umeda Clinic

🇯🇵

Osaka, Japan

Saga Memorial Hospital

🇯🇵

Saga, Saga, Japan

SAINO Clinic,

🇯🇵

Saitama, Tokorozawa, Japan

Shinkoiwa Ekimae Sougou Clinic

🇯🇵

Tokyo, Katushika-ku, Japan

Plumeria Clinic, Shizuoka, I.M.

🇯🇵

Shizuoka, Shizuoka, Japan

Wakakusa Clinic, Tochigi, I.M.

🇯🇵

Tochigi, Shimotsuke, Japan

Nihonbashi Enomoto Internal Medicine

🇯🇵

Tokyo, Chuo-ku, Japan

New Medical Research System Clinic

🇯🇵

Tokyo, Hachioji, Japan

Medical Corporation Keikokai P1-Clinic

🇯🇵

Tokyo, Hachioji, Japan

Minamino Heart Clinic

🇯🇵

Tokyo, Hachioji, Japan

Hosono Clinic

🇯🇵

Tokyo, Chuo-ku, Japan

Shinagawa East one Medical Clinic

🇯🇵

Tokyo, Minato-ku, Japan

Kasai Diabetes Clinic

🇯🇵

Tokyo, Edogawa-ku, Japan

Musashino Polyclinic

🇯🇵

Tokyo, Kiyose, Japan

Miho Clinic

🇯🇵

Tokyo, Shinagawa-ku, Japan

Shimamura Kinen Hospital

🇯🇵

Tokyo, Nerima-ku, Japan

Kenkoukan Suzuki Clinic

🇯🇵

Tokyo, Ota-ku, Japan

Sakayori Clinic

🇯🇵

Tokyo, Shinagawa-ku, Japan

ToCROM Clinic

🇯🇵

Tokyo, Shinjuku-ku, Japan

Ikebukuro Metropolitan Clinic

🇯🇵

Tokyo, Toshima-ku, Japan

Fujikoshi Hp., Toyama, I.M.

🇯🇵

Toyama, Toyama, Japan

Matsuyama Shimin Hospital

🇯🇵

Ehime, Matsuyama, Japan

Medical Corporation Toujinkai Sakado Central Hospital

🇯🇵

Saitama, Sakado, Japan

Tokyo-Eki Center-building Clinic

🇯🇵

Tokyo, Chuo-ku, Japan

Tokyo Center Clinic

🇯🇵

Tokyo, Chuo-ku, Japan

Pedi Shiodome Clinic

🇯🇵

Tokyo, Minato-ku, Japan

© Copyright 2025. All Rights Reserved by MedPath